)
Sohini Das leads the automobile and healthcare verticals at Business Standard. In her 17 years as a journalist, she has written on myriad subjects and sectors -- FMCG, dairies, tourism, and state elections, among others, across Kolkata, Ahmedabad and now Mumbai. She loves doing personality stories and ground reportage.
Sohini Das leads the automobile and healthcare verticals at Business Standard. In her 17 years as a journalist, she has written on myriad subjects and sectors -- FMCG, dairies, tourism, and state elections, among others, across Kolkata, Ahmedabad and now Mumbai. She loves doing personality stories and ground reportage.
Sees huge potential in day-care market, seeks tie up with those firms that also cover such expenses
The creation of the Amul brand and its famous mascot gave a rural revolution a durable competitive edge
Proposed investment dip 33% from Rs 1.42 lakh cr in 2011 to Rs 94,259 cr in 2013
Senior officials from the Brazilian regulator ANVISA are likely to interact with their Indian counterparts to take the process further
Led by ex-Paras Pharma promoter, company expects inorganic growth as well as JVs to fuel growth
Industry insiders feel focus should be on encouraging manufacturing medical devices in country
Officials from Peru to visit India to understand details about the loan licensing system
Plans to build two onclology centers at Ahmedabad, Vadodara under Sterling brand
Zydus is accused of infringing patents related to a drug used to treat Alzheimer's and Parkinson's diseases
Interview with Managing Director, Hinduja Group
Twenty-year-old Ripal Prajapati had to settle for mailing a 'rakhi' to her god-brother this time around
The company has already started work on the site even as it waits for shareholder approval regarding the Suzuki subsidiary building the plant
According to data from GITCO, tourist flow in last 2 years has grown by 34.6%
Vinod Dasari said the company may increase prices by up to 2%, even as it continues to battle debt
The industry claims that India is increasingly becoming import dependent, nearly 70-75% of all medical devices used in the country are imported
GIDC has already started work on developing an electronic manufacturing zone on over 100 Ha at Khoraj, about 17 km from Sanand
Sun Pharma to retain these in most markets; US could be the exception, where the Ranbaxy name has taken a hit
Indian Pharmacist Association says pharmacists would require additional training to double up as non-doctor medical cadre in rural areas
Says such a move is sure to kill small and medium pharma manufacturer in the long run